All In Biotech

Drug Trial Radar · NCT07226089

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Multicenter Interventional Study: Somatrogon Impact on Outcomes in Naive Small for Gestational Age or Idiopathic Short Stature Pediatric Patients Compared With Daily Growth Hormone

Last checked: Nov 20, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 254 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

254

Planned (sponsor's estimate)

Start

Feb 1, 2026

Primary completion

Dec 2027

Study completion Jan 2028

Sponsor

Lead sponsor
Rabin Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Pfizer
First posted
Nov 10, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 3 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a randomized, open-label, active controlled, parallel group study comparing the efficacy and safety of once weekly Somatrogon to daily Growth Hormone (Genotropin) in pre-pubertal children with short stature either born Small for Gestational Age (SGA) or with Idiopathic Short Stature (ISS). The planned study duration is 12 months with a screening period of up to 30 days. The study will consist of two groups: 140 children with SGA who are naïve to GH treatment will be randomized 1:1 to receive either Somatrogon or Genotropin for 12 months. A second group will include 114 children with ISS who are naïve to GH treatment who will be randomized 1:1 to receive either Somatrogon or Genotropin for 12 months.

Conditions

  • ISS
  • SGA

Interventions

  • SomatrogonDrug

    Once weekly Growth Hormone

  • GenotropinDrug

    Daily Growth Hormone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annual Height VelocityTime frame: • Annualized HV after 12 months of treatment

Locations

32 sites in 5 countries. Site status is shown where the registry gives one.

  • University of California Los Angeles (UCLA) - Mattel Children's Hospital

    Los Angeles, California · Not yet recruiting

  • Rocky Mountain Pediatric Endocrinology

    Centennial, Colorado · Not yet recruiting

  • Nemours Children's Clinic - Jacksonville

    Jacksonville, Florida · Not yet recruiting

  • Children's Minnesota - Minneapolis

    Minneapolis, Minnesota · Not yet recruiting

  • Hackensack University Medical Center

    Hackensack, New Jersey · Not yet recruiting

  • Atlantic Health System

    Morristown, New Jersey · Not yet recruiting

  • Rutgers Robert Wood Johnson Medical School - The Child Heath Institute of New Jersey

    New Brunswick, New Jersey · Not yet recruiting

  • The State University of New York (SUNY) School of Medicine and Biomedical Sciences

    Buffalo, New York · Not yet recruiting

  • Hassenfeld Children's Hospital at NYU Langone

    New York, New York · Not yet recruiting

  • Dell Children's Medical Group

    Austin, Texas · Not yet recruiting

  • Cook Children's Medical Center

    Fort Worth, Texas · Not yet recruiting

  • The University of Utah

    Salt Lake City, Utah · Not yet recruiting

  • Centre Hospitalier Universitaire d'Angers

    Angers, France · Not yet recruiting

  • Hôpital Bicêtre

    Le Kremlin-Bicêtre, France · Not yet recruiting

  • Chu de Lyon - Hopital Femme Mere Enfant

    Lyon, France · Not yet recruiting

  • CHU Hôpital de la Timone

    Marseille, France · Not yet recruiting

  • Hôpital Armand-Trousseau

    Paris, France · Not yet recruiting

  • Hôpital Necker - Enfants Malades

    Paris, France · Not yet recruiting

  • Jehangir Hospital

    Maheshra, India · Not yet recruiting

  • Apollo Hospitals Enterprise Limited

    Navi Mumbai, India · Not yet recruiting

  • All India Institute of Medical Sciences (AIIMS) - New Delhi

    New Delhi, India · Not yet recruiting

  • Sir Ganga Ram Hospital

    New Delhi, India · Not yet recruiting

  • Soroka hospital

    Bear Sheva, Israel · Not yet recruiting

  • Sheba Medical Center

    Ramat Gan, Israel · Not yet recruiting

  • Assaf Harofe Medical Center

    Rishon LeZiyyon, Israel · Not yet recruiting

  • Dana-Duek children's hospital

    Tel Aviv, Israel · Not yet recruiting

  • Shaare Zedek Medical Center

    Jerusalem, Israe, Israel · Not yet recruiting

  • Schneider Children Medical Center- the institute of Endocrinology and Diabetes

    Petah Tikva, Israel, Israel · Recruiting

  • Osaka Women's and Children's Hospital

    Izumi-Shi, Japan · Not yet recruiting

  • Nara Prefecture General Medical Center

    Nara, Japan · Not yet recruiting

  • Osaka City General Hospital

    Osaka, Japan · Not yet recruiting

  • National Center for Child Health and Development

    Setagaya-Ku, Japan · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.